Publicaciones (77) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. e323-e329

  2. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

    Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 1061-1071

  3. ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer

    Oncotarget, Vol. 9, Núm. 24, pp. 16648-16664

  4. ARole forCXCR4in peritonealandhematogenous ovarian cancer dissemination

    Molecular Cancer Therapeutics, Vol. 17, Núm. 2, pp. 532-543

  5. Abordaje del paciente con cáncer renal: ¿existe la colaboración entre urología y oncología?

    Actas Urologicas Espanolas

  6. Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 4, pp. 510-520

  7. Analysis of the relationship between heading N / L and survival in patients treated with immunotherapy in lung cancer

    ANNALS OF ONCOLOGY, Vol. 29, Núm. Supl 8, pp. 1495P

  8. Aspectos médico-legales en RCP en gestantes

    Manual de soporte vital en gestante para personal de urgencias hospitalarias y extrahospitalarias (ARAN), pp. 197

  9. Assessment and treatment of breakthrough cancer pain in Spain: A self-audit study

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii611-viii612

  10. Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib

    Oncotarget, Vol. 9, Núm. 97, pp. 36894-36905

  11. Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer

    New England Journal of Medicine, Vol. 379, Núm. 21, pp. 2027-2039

  12. Cell migration in tissues: Explant culture and live imaging

    Methods in Molecular Biology (Humana Press Inc.), pp. 163-173

  13. Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC

    Translational Lung Cancer Research, Vol. 7, Núm. 6, pp. 691-702

  14. Challenges in lung cancer screening in Latin America

    Journal of Global Oncology, Vol. 2018, Núm. 4

  15. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis

    Journal of the National Cancer Institute, Vol. 110, Núm. 6, pp. 560-567

  16. Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii612

  17. Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial

    JAMA Oncology, Vol. 4, Núm. 3, pp. 302-308

  18. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

    Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1467-1473

  19. Cyclosporine-loaded cross-linked inserts of sodium hyaluronan and hydroxypropyl-β-cyclodextrin for ocular administration

    Carbohydrate Polymers, Vol. 201, pp. 308-316

  20. Dental management prior to radiation therapy in patients with head and neck cancer

    Indian Journal of Cancer, Vol. 55, Núm. 3, pp. 251-256